2 days BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLXZacks
Boston Scientific announces favorable OPTION trial results for its WATCHMAN FLX LAAC device. In terms of stroke risk reduction, WATCHMAN FLX is found to be superior to OAC therapy.
Boston · Boston Scientific (BSX)
X